Ariad CEO to Retire Due to Pressure From Shareholders

Harvey Berger, who co-founded Ariad Pharmaceuticals 23 years ago and oversaw the development and launch of its leukemia drug, Iclusig, is stepping down after months of pressure from shareholders and board members...